Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

577 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Exclusion of Older Adults in COVID-19 Clinical Trials.
Abi Jaoude J, Kouzy R, El Alam MB, Subbiah V, Taniguchi CM, Ludmir EB, Lin TA. Abi Jaoude J, et al. Among authors: subbiah v. Mayo Clin Proc. 2020 Oct;95(10):2293-2294. doi: 10.1016/j.mayocp.2020.08.018. Epub 2020 Aug 14. Mayo Clin Proc. 2020. PMID: 33012364 Free PMC article. No abstract available.
Managing Cancer Care during the COVID-19 Pandemic and Beyond.
Alhalabi O, Subbiah V. Alhalabi O, et al. Among authors: subbiah v. Trends Cancer. 2020 Jul;6(7):533-535. doi: 10.1016/j.trecan.2020.04.005. Epub 2020 Apr 27. Trends Cancer. 2020. PMID: 32386875 Free PMC article.
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
Kuderer NM, Choueiri TK, Shah DP, Shyr Y, Rubinstein SM, Rivera DR, Shete S, Hsu CY, Desai A, de Lima Lopes G Jr, Grivas P, Painter CA, Peters S, Thompson MA, Bakouny Z, Batist G, Bekaii-Saab T, Bilen MA, Bouganim N, Larroya MB, Castellano D, Del Prete SA, Doroshow DB, Egan PC, Elkrief A, Farmakiotis D, Flora D, Galsky MD, Glover MJ, Griffiths EA, Gulati AP, Gupta S, Hafez N, Halfdanarson TR, Hawley JE, Hsu E, Kasi A, Khaki AR, Lemmon CA, Lewis C, Logan B, Masters T, McKay RR, Mesa RA, Morgans AK, Mulcahy MF, Panagiotou OA, Peddi P, Pennell NA, Reynolds K, Rosen LR, Rosovsky R, Salazar M, Schmidt A, Shah SA, Shaya JA, Steinharter J, Stockerl-Goldstein KE, Subbiah S, Vinh DC, Wehbe FH, Weissmann LB, Wu JT, Wulff-Burchfield E, Xie Z, Yeh A, Yu PP, Zhou AY, Zubiri L, Mishra S, Lyman GH, Rini BI, Warner JL; COVID-19 and Cancer Consortium. Kuderer NM, et al. Lancet. 2020 Jun 20;395(10241):1907-1918. doi: 10.1016/S0140-6736(20)31187-9. Epub 2020 May 28. Lancet. 2020. PMID: 32473681 Free PMC article.
Progression-free survival is a suboptimal predictor for overall survival among metastatic solid tumour clinical trials.
Pasalic D, McGinnis GJ, Fuller CD, Grossberg AJ, Verma V, Mainwaring W, Miller AB, Lin TA, Jethanandani A, Espinoza AF, Diefenhardt M, Das P, Subbiah V, Subbiah IM, Jagsi R, Garden AS, Fokas E, Rödel C, Thomas CR Jr, Minsky BD, Ludmir EB. Pasalic D, et al. Among authors: subbiah im, subbiah v. Eur J Cancer. 2020 Sep;136:176-185. doi: 10.1016/j.ejca.2020.06.015. Epub 2020 Jul 20. Eur J Cancer. 2020. PMID: 32702645 Free PMC article. Review.
Trial Sponsorship and Time to Reporting for Phase 3 Randomized Cancer Clinical Trials.
Lin TA, Fuller CD, Verma V, Mainwaring W, Espinoza AF, Miller AB, Jethanandani A, Pasalic D, Das P, Minsky BD, Thomas CR Jr, Fogelman DR, Subbiah V, Subbiah IM, Ludmir EB. Lin TA, et al. Among authors: subbiah im, subbiah v. Cancers (Basel). 2020 Sep 16;12(9):2636. doi: 10.3390/cancers12092636. Cancers (Basel). 2020. PMID: 32947844 Free PMC article.
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials.
Desai A, Gainor JF, Hegde A, Schram AM, Curigliano G, Pal S, Liu SV, Halmos B, Groisberg R, Grande E, Dragovich T, Matrana M, Agarwal N, Chawla S, Kato S, Morgan G, Kasi PM, Solomon B, Loong HH, Park H, Choueiri TK, Subbiah IM, Pemmaraju N, Subbiah V; COVID19 and Cancer Clinical Trials Working Group. Desai A, et al. Among authors: subbiah im, subbiah v. Nat Rev Clin Oncol. 2021 May;18(5):313-319. doi: 10.1038/s41571-021-00487-z. Epub 2021 Mar 15. Nat Rev Clin Oncol. 2021. PMID: 33723371 Free PMC article. Review.
Food and Drug Administration approvals in phase 3 Cancer clinical trials.
Abi Jaoude J, Kouzy R, Ghabach M, Patel R, Pasalic D, Ghossain E, Miller AB, Lin TA, Verma V, Fuller CD, Subbiah V, Minsky BD, Ludmir EB, Taniguchi CM. Abi Jaoude J, et al. Among authors: subbiah v. BMC Cancer. 2021 Jun 12;21(1):695. doi: 10.1186/s12885-021-08457-5. BMC Cancer. 2021. PMID: 34118915 Free PMC article. Clinical Trial.
Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trials.
Sen S, Hess K, Hong DS, Naing A, Piha-Paul S, Janku F, Fu S, Subbiah IM, Liu H, Khanji R, Huang L, Moorthy S, Karp DD, Tsimberidou A, Meric-Bernstam F, Subbiah V. Sen S, et al. Among authors: subbiah im, subbiah v. Br J Cancer. 2018 Mar 20;118(6):763-769. doi: 10.1038/bjc.2017.480. Epub 2018 Feb 20. Br J Cancer. 2018. PMID: 29462132 Free PMC article.
577 results